Literature DB >> 9685399

Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer.

J A Engelman1, R J Lee, A Karnezis, D J Bearss, M Webster, P Siegel, W J Muller, J J Windle, R G Pestell, M P Lisanti.   

Abstract

Neu (c-erbB2) is a proto-oncogene product that encodes an epidermal growth factor-like receptor tyrosine kinase. Amplification of wild-type c-Neu and mutational activation of Neu (Neu T) have been implicated in oncogenic transformation of cultured fibroblasts and mammary tumorigenesis in vivo. Here, we examine the relationship between Neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Recent studies have suggested that caveolins may function as negative regulators of signal transduction. Our current results show that mutational activation of c-Neu down-regulates caveolin-1 protein expression, but not caveolin-2, in cultured NIH 3T3 and Rat 1 cells. Conversely, recombinant overexpression of caveolin-1 blocks Neu-mediated signal transduction in vivo. These results suggest a reciprocal relationship between c-Neu tyrosine kinase activity and caveolin-1 protein expression. We next analyzed a variety of caveolin-1 deletion mutants to map this caveolin-1-dependent inhibitory activity to a given region of the caveolin-1 molecule. Results from this mutational analysis show that this functional in vivo inhibitory activity is contained within caveolin-1 residues 32-95. In accordance with these in vivo studies, a 20-amino acid peptide derived from this region (the caveolin-1 scaffolding domain) was sufficient to inhibit Neu autophosphorylation in an in vitro kinase assay. To further confirm or refute the relevance of our findings in vivo, we next examined the expression levels of caveolin-1 in mammary tumors derived from c-Neu transgenic mice. Our results indicate that dramatic reduction of caveolin-1 expression occurs in mammary tumors derived from c-Neu-expressing transgenic mice and other transgenic mice expressing downstream effectors of Neu-mediated signal transduction, such as Src and Ras. Taken together, our data suggest that a novel form of reciprocal negative regulation exists between c-Neu and caveolin-1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9685399     DOI: 10.1074/jbc.273.32.20448

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

Review 1.  Caveolins, liquid-ordered domains, and signal transduction.

Authors:  E J Smart; G A Graf; M A McNiven; W C Sessa; J A Engelman; P E Scherer; T Okamoto; M P Lisanti
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic system.

Authors:  Yashodhar P Bhandary; Shwetha K Shetty; Amarnath S Marudamuthu; Margaret R Gyetko; Steven Idell; Mehrnaz Gharaee-Kermani; Rashmi S Shetty; Barry C Starcher; Sreerama Shetty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-02       Impact factor: 5.464

3.  Changes in mammary caveolin-1 signaling pathways are associated with breast cancer risk in rats exposed to estradiol in utero or during prepuberty.

Authors:  Ayesha N Shajahan; Shruti Goel; Sonia de Assis; Bin Yu; Robert Clarke; Leena Hilakivi-Clarke
Journal:  Horm Mol Biol Clin Investig       Date:  2010-06

4.  Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status.

Authors:  Tianhong Li; Federica Sotgia; Magalis A Vuolo; Maomi Li; Wan Cai Yang; Richard G Pestell; Joseph A Sparano; Michael P Lisanti
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

Review 5.  Caveolin-1: a critical regulator of lung injury.

Authors:  Yang Jin; Seon-Jin Lee; Richard D Minshall; Augustine M K Choi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-19       Impact factor: 5.464

6.  Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C.

Authors:  Daniela Volonte; Aaron J Peoples; Ferruccio Galbiati
Journal:  Mol Biol Cell       Date:  2003-08-07       Impact factor: 4.138

7.  Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells.

Authors:  Terence M Williams; Federica Sotgia; Hyangkyu Lee; Ghada Hassan; Dolores Di Vizio; Gloria Bonuccelli; Franco Capozza; Isabelle Mercier; Hallgeir Rui; Richard G Pestell; Michael P Lisanti
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

8.  Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade.

Authors:  F Galbiati; D Volonte; J A Engelman; G Watanabe; R Burk; R G Pestell; M P Lisanti
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

9.  Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells.

Authors:  Caterina Bianco; Luigi Strizzi; Mario Mancino; Kazuhide Watanabe; Monica Gonzales; Shin Hamada; Ahmed Raafat; Lawson Sahlah; Cindy Chang; Federica Sotgia; Nicola Normanno; Michael Lisanti; David S Salomon
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

10.  Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury.

Authors:  F Galbiati; D Volonte; O Gil; G Zanazzi; J L Salzer; M Sargiacomo; P E Scherer; J A Engelman; A Schlegel; M Parenti; T Okamoto; M P Lisanti
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.